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Abstract Activation of protein kinase C (PKC) by phorbol 12-myristate 13-acetic ac d (PMA) stimulates DNA synthesis in human glomerular 
mesangial cells. Incubation of these cells with PMA stimulates the tyrosine phosphorylation f a set of proteins ranging from 110 to 39 kDa with 
different ime kinetics. PMA inhibits total protein tyrosine phosphatase (PTPase) activity in these cells. Immunoprecipitation of PTP1B, an 
intracytoplasmic tyrosine phosphatase, with subsequent assay of the immunobeads for PTPase shows a significant inhibition of its activity in 
PMA-treated cells. Immunoblot analysis of mesangial cell lysates using the same antibody revealed that PMA does not affect he level of this 50 kDa 
PTP1B protein. These data indicate that inhibition of total PTPase, and specifically PTPIB, activity may provide a mechanism for stimulation of 
tyrosine phosphorylation byPMA in these ceils and thereby contribute to its mitogenic effect. 
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1. Introduction 
Increased DNA synthesis and proliferation of mesangial cells 
is a common abnormality and may be a marker of activity in 
glomerular diseases [1,2]. PKC may mediate the mitogenic ef- 
fect of cytokines expressed in renal disease. We have recently 
shown that PKC may mediate PDGF-induced DNA synthesis 
in these cells [3]. The potent PKC activator, PMA, has been 
widely used to study the role of PKC in different biological 
processes [4]. We have shown that PMA stimulates DNA syn- 
thesis in mesangial cells [5]. PMA has also been shown to 
stimulate tyrosine phosphorylation of several proteins in cul- 
tured cells [6-9]. The specific tyrosine kinase(s) involved in this 
phosphorylation process are not known. However, the level of 
tyrosine phosphorylation depends upon the competing action 
of kinases and phosphatases which catalyze phosphorylation 
and dephosphorylation reactions, respectively. Therefore it is 
important o identify and characterize the protein tyrosine 
phosphatases (PTPases) involved in this dynamic equilibrium. 
PTPases are a family of enzymes which include receptor type 
and intracellular proteins [10]. The non-receptor PTPases com- 
prise a catalytic domain fused to regulatory motifs which have 
homology with cytoskeletal proteins, SH2 domains and PEST 
sequences [10]. The most characterized non-transmembrane 
PTPase is PTP1B, which was originally isolated from human 
placenta nd found to be expressed ubiquitously [11,12]. It has 
recently been shown that PTP1B is phosphorylated by PKC 
[13]. In this study we demonstrate that PMA inhibits total 
PTPase and FrP1B activity in human mesangial cells. Inhibi- 
tion of PTPases by PMA may contribute to stimulation of 
tyrosine phosphorylation a d mitogenesis in response to PMA. 
2. Experimental 
2.1. Materials 
PMA, myelin basic protein (MBP), Triton X-100, phenylmethylsul- 
*Corresponding author. Fax: (1) (210) 567-4654. 
fonyl fluoride (PMSF) and charcoal (Norit A) were obtained from 
Sigma, St. Louis, MO. Aprotinin was purchased from Miles Labora- 
tory, Kankakee, IL. p60 ~'s~ tyrosine kinase was from Oncogene Sci- 
ence, Uniondale, NY. Monoclonal antiphosphotyrosine a tibody and 
polyclonal PTP1 B antibody were obtained from UBI, Lake Placid, NY. 
A431 epidermal carcinoma cell lysate was purchased from Transduc- 
tion Laboratories, Lexington, KY. ECL immunoblotting reagents were 
purchased from Amersham, Arlington Heights, IL. Protein A-Sepha- 
rose beads were obtained from Pharmacia, Piscataway, NJ. All other 
chemicals were of analytical grade. 
2.2. Cell culture 
Mesangial cells from collagenase-treated glomeruli of normal human 
kidney were cultured in Waymouth's medium in the presence of 17% 
fetal bovine serum as described before [3]. Confluent cells were made 
quiescent by incubation i  serum-free medium for 3 days. Quiescent 
cells were treated with 100 nM PMA for indicated periods of time. 
2.3. Immunoblot analysis 
The cells were lysed in buffer A (50 mM HEPES, pH 7.4, 5 mM 
EDTA, 0.25 M sucrose, 1% Triton X-100, 115 pM PMSF, 0.05% 
aprotinin, 5mM benzamidine) for 30 min at 4°C. After centrifugation 
at 10,000 x g for 30 min the protein concentration in the supernatant 
was determined. Equal amounts of cell lysate were analyzed on 7.5% 
polyacrylamide g ls, and separated proteins were electrophoretically 
transferred topolyvinyl membranes. Western immunoblotting analysis 
of the proteins was performed using either a monoclonal anti- 
phosphotyrosine antibody or a polyclonal PTP1B antibody. The de- 
tailed procedure has been published recently [14]. 
2.4. Immunoprecipitation 
Equal amounts of cleared cell lysate were incubated with 3 ktl (1/.tg) 
of PTP1B antibody on ice for 30 min. 15/~1 of protein A-Sepharose 
beads (50% v/v slurry) were added and incubated at 4°C on a rocking 
platform for 2 h. The beads were washed once with buffer A without 
aprotinin, twice with double-distilled water, and once with 25 mM 
HEPES, pH 7.3, and then assayed for PTPase activity. 
2.5. PTPase assay 
MBP substrate was tyrosine phosphorylated by p60 ~src and 
[~,-32p]ATP as previously described [15]. The PTPase assay was per- 
formed according to the method of Tonks et al. [11,12] with minor 
modification. Briefly, 0.5 gg cell lysate or the PTP1B immunoprecipi- 
tates were incubated with tyrosine-phosphorylated 32p-labeled MBP. 
The reaction was carded out in 50 gl buffer (25 mM HEPES, pH 7.3, 
5 mM EDTA, 10 mM DTT) at 30°C for 30 min. Incubation was 
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stopped by adding 0.75 ml of acidic charcoal mixture. The mixture was 
centrifuged at10,000 x g for 10 min and the 32p i released inthe 400/21 
supernatant was determined in a scintilation counter. Initially the assay 
was standardized to show linearity with protein ranging from 0.125 to 
5.0/2g, and the dephosphorylation was linear within 1.0 ,ug of protein. 
The PTPase activity was expressed relative to the control, set as 100%.
Independent experiments were used to express the data as 
mean + S.E.M. 
3. Results 
3.1. Stimulation of  tyrosine phosphorylation i mesangial cells 
Addition of 100 nM PMA to human mesangial cells stimu- 
lated tyrosine phosphorylation f multiple proteins in a time- 
dependent manner (Fig. 1). Tyrosine phosphorylation of a 
110 kDa protein was stimulated within 5 min of PMA addition 
and persisted for 20 rain. The tyrosine-phosphorylated proteins 
migrating at 85, 79 and 44 kDa were stimulated at 10 min after 
the addition of PMA. Tyrosine phosphorylated 60and 39 kDa 
proteins were stimulated at 20 and 30 min, respectively. The 
identity of all these proteins, with the exception of the 44 kDa 
one, is not known. The 44 kDa tyrosine-phosphorylated pro-
tein is most likely mitogen-activated protein kinase. Nearly 
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Fig. 1. Effect of PMA on tyrosine phosphorylation. Quiescent human
mesangial cells were treated with 100 nM PMA for different periods f 
time. 50/2g ofcell lysate was analyzed by immunoblotting using anti- 
phosphotyrosine antibody as described in section 2. Molecular weight 
markers are shown in kDa. The arrowheads indicate the protein bands 
the tyrosine phosphorylation of which is enhanced by PMA. 
Their molecular weights from top to bottom are 110, 85, 79, 60, 44 and 
39 kDa. 
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Fig. 2. Effect of PMA on total PTPase activity. Quiescent human 
mesangial cells were stimulated with 100 nM PMA for the indicated 
periods of time. PTPase activity was determined in 0.5/2g of cell lysate 
as described insection 2. *P < 0.05. 
similar patterns of tyrosine phosphorylation were reported in 
rat mesangial cells [9]. These data indicate that PMA stimulates 
tyrosine phosphorylation f several proteins with different time 
kinetics. 
3.2. Inhibition of  PTPase activity 
Since the level of tyrosine-phosphorylated proteins in the cell 
depends upon the balanced activity of tyrosine kinases and 
tyrosine phosphatases, we measured total PTPase activity of 
mesangial cell lysate after stimulation with PMA. At 20 min the 
activity was reduced to 85%, whereas at 30 min a significant 
reduction to 60% of the basal activity was observed (Fig. 2). 
These results indicate that the PMA-induced stimulation of 
tyrosine phosphorylation seen above (Fig. 1) may be partially 
mediated by the inhibition of PTPases. 
3.3. Effect of PMA on PTP1B activity 
The intracellular PTPase, PTP1B, is expressed ubiquitously. 
We first characterized a polyclonal antibody raised against an 
N-terminal fusion protein of PTP1B in an immune complex 
phosphatase assay. Different amounts of mesangial cell lysate 
were immunoprecipitated with PTP 1B antibody. The immuno- 
beads were assayed for PTPase activity. The data show that 
PTP1B antibody does not inhibit the phosphatase activity of 
the immunoprecipitated enzyme (Fig. 3A). To test the effect of 
PMA on the activity ofPTP 1 B, mesangial cells were stimulated 
with PMA for 20 or 30 min. After protein determination, equal 
amounts of cell lysate were immunoprecipitated with PTP1B 
antibody. The immunobeads were assayed for PTPase activity. 
The data show that PMA inhibited PTP1B activity by 25 and 
43% at 20 and 30 min, respectively (Fig. 3B). To test he effect 
of PMA on the level of PTPIB protein, we determined the 
amount of the enzyme by immunoblot analysis (Fig. 4). In 
mesangial cells, the antibody identified the 50 kDa PTP1B 
protein (indicated by an arrow). PMA treatment did not affect 
the level of PTP1B protein (Fig. 4, compare lanes 2 and 3 with 
1). These data suggest hat the inhibitory effect of PMA on 
PTP1B activity was not due to the loss of PTP1B protein. 
Furthermore PTP1B antibody recognized a 46 kDa protein 
in mesangial cells (Fig. 4, lanes 1-3). This protein is not 
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present in the human epidermal carcinoma cell line, A431 
(Fig. 4, lane 4). 
4. Discussion 
Cytokines and other agonists act on receptors with intrinsic 
tyrosine kinase activity, as well as on non-tyrosine kinase recep- 
tors, to stimulate PKC. Thus activation of PKC in vivo is a 
central signal that mediates the action of several agonists. We 
show that PMA, a potent activator of PKC [4], stimulates 
tyrosine phosphorylation of different proteins with specific 
time kinetics (Fig. 1), as has been reported in rat mesangial cells 
[9]. 
To investigate he role of PTPases, we measured total PTPase 
activity of cell lysates timulated with PMA (Fig. 2). Inhibition 
of PTPase activity is consistent with the observation that PMA 
stimulates tyrosine phosphorylation f a panel of proteins. Al- 
though we cannot rule out the possibility of activation of tyro- 
sine kinase(s) by PMA, at least its inhibitory effect on PTPase 
activity may provide an alternative mechanism of stimulation 
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Fig. 3. (A) Detection of PTP1B activity in human mesangial cells. 
Different amounts of cell extracts were immunoprecipitated with 
PTP1B antibody, as described insection 2, and the immunobeads were 
assayed for PTPase activity. (B) Effect of PMA on PTP1B activity. Cells 
were stimulated as in Fig. 2. Immunoprecipitates of PTP1B from equal 
amounts of cell lysate were assayed for PTPase activity, as described 
in section 2. *P < 0.01. 
200 
97 
68 
46 
1 2 3 4 
Fig. 4. Immunoblot analysis of PTP1B protein. Quiescent human me- 
sangial cells were stimulated with PMA for different periods of time. 
Cells were lysed in buffer A and50/zg of the cell lysate (lanes 1-3) and 
10/tg of A431 cell lysate (lane 4) were s parated on a SDS gel and 
analyzed by immunoblotting using PTP1B antibody. Lane 1, unstimu- 
lated; lanes 2 and 3, 20 and 30 min after PMA treatment. Molecular 
weight markers are shown in kDa. The arrow indicates the 50 kDa 
PTP1B enzyme in both cells. 
of tyrosine phosphorylation in mesangial cells. Our results are 
in contrast o a recent report that PMA decreases the EGF- 
dependent tyrosine phosphorylation of proteins in NIH 3T3 
fibroblasts transfected with EGF receptor via stimulation of 
PTPases [16]. Taken together these data suggest that the effect 
of PMA is likely to be cell-type specific. 
Similar to several other signalling enzymes, phosphorylation 
of PTPases may provide a mechanism of their enzymatic activa- 
tion. Thus phosphorylation of a 55 kDa membrane-bound 
PTPase by protein kinase A or PKC stimulates its enzymatic 
activity [17]. The best-characterized intracytoplasmic PTPase, 
PTP1B, is a phosphoprotein, and the phosphorylation pattern 
is cell cycle specific [18]. It has recently been shown that PMA 
treatment of HeLa cells stimulates phosphorylation f Ser 37s of 
PTP1B [13]. This same residue is also phosphorylated in vitro 
by purified PKC [13]. In this report, we provide evidence that 
treatment of human mesangial cells with PMA inhibits PTP1B 
activity (Fig. 3B). Whether this inhibition is due to the phos- 
phorylation of PTP1B by PKC in vivo or involves modulation 
of PTP 1 B by some other protein(s) which is regulated by PKC, 
is not clear. However, immunoblot analysis of mesangial cell 
lysate revealed that the PTP1B protein is not regulated by PMA 
treatment (Fig. 4). This result indicates that the inhibition of 
PTP1B activity is not due to down-modulation f the protein 
by PMA. Along with 50 kDa PTP1B, we also detected a 46 kDa 
protein in mesangial cells (Fig. 4). This protein was not found 
in A431 epidermal carcinoma cells or in other cell types tudied 
previously [18]. Taken together these data provide the first 
evidence that in mesangial cells PMA inhibits PTP1B activity. 
Inhibition of PTP1B may mediate, at least partially, the stimu- 
lation of tyrosine phosphorylation, and thereby contribute to 
its mitogenic effect. 
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